Pain

Editorial list
pp. iii-iii(1)

Instructions to authors
pp. v-vi(2)

Numbers need to careSee related article by Erickson et al., Pages 221 to 228 of this issue
pp. 213-214(2)
Author: McQuay H.

Neurons involved in the exteroceptive function of pain
pp. 215-219(5)
Authors: Price D.D.; Greenspan J.D.; Dubner R.

Epidemiology of chronic non-malignant pain in Denmark
pp. 221-228(8)
Authors: Eriksen J.; Jensen M.K.; Sjogren P.; Ekholm O.; Rasmussen N.K.

Chronic hyperalgesia induced by repeated acid injections in muscle is abolished by the loss of ASIC3, but not ASIC1
pp. 229-239(11)
Authors: Sluka K.A.; Price M.P.; Breese N.M.; Stucky C.L.; Wemmie J.A.; Welsh M.J.

Interferon- induces characteristics of central sensitization in spinal dorsal horn neurons in vitro
pp. 241-251(11)
Authors: Vikman K.S.; Hill R.H.; Backstrom E.; Robertson B.; Kristensson K.

Changes in temporomandibular pain and other symptoms across the menstrual cycle
pp. 253-261(9)
Authors: LeResche L.; Mancl L.; Sherman J.J.; Gandara B.; Dworkin S.F.

Can complex regional pain syndrome be painless?
pp. 263-267(5)
Authors: Eisenberg E.; Melamed E.

The role of spinal nitric oxide and glutamate in nociceptive behaviour evoked by high-dose intrathecal morphine in rats
pp. 269-283(15)
Authors: Watanabe C.; Sakurada T.; Okuda K.; Sakurada C.; Ando R.; Sakurada S.

Blood pressure but not cortisol mediates stress effects on subsequent pain perception in healthy men and women
pp. 285-295(11)
Authors: al'Absi M.; Petersen K.L.

Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain
pp. 297-307(11)
Authors: Mousa S.A.; Bopaiah C.P.; Stein C.; Schafer M.

Initial pharmacokinetic, safety and efficacy evaluation of nasal morphine gluconate for breakthrough pain in cancer patients
pp. 309-315(7)
Authors: Fitzgibbon D.; Morgan D.; Dockter D.; Barry C.; Kharasch E.D.

The association between anger expression and chronic pain intensity: evidence for partial mediation by endogenous opioid dysfunction
pp. 317-324(8)
Authors: Bruehl S.; Chung O.Y.; Burns J.W.; Biridepalli S.

Genotype-dependence of gabapentin and pregabalin sensitivity: the pharmacogenetic mediation of analgesia is specific to the type of pain being inhibited
pp. 325-335(11)
Authors: Chesler E.J.; Ritchie J.; Kokayeff A.; Lariviere W.R.; Wilson S.G.; Mogil J.S.

Core outcome domains for chronic pain clinical trials: IMMPACT recommendations
pp. 337-345(9)
Authors: Turk D.C.; Dworkin R.H.; Allen R.R.; Bellamy N.; Brandenburg N.; Carr D.B.; Cleeland C.; Dionne R.; Farrar J.T.; Galer B.S.; Hewitt D.J.; Jadad A.R.; Katz N.P.; Kramer L.D.; Manning D.C.; McCormick C.G.; McDermott M.P.; McGrath P.; Quessy S.; Rappaport B.A.; Robinson J.P.; Royal M.A.; Simon L.; Stauffer J.W.; Stein W.; Tollett J.; Witter J.

Alterations in dorsal horn neurones in a rat model of cancer-induced bone pain
pp. 347-356(10)
Authors: Urch C.E.; Donovan-Rodriguez T.; Dickenson A.H.

Factor analysis validates the cluster structure of the dendrogram underlying the Multidimensional Affect and Pain Survey (MAPS) and challenges the a priori classification of the descriptors in the McGill Pain Questionnaire (MPQ)
pp. 357-363(7)
Authors: Clark W.C.; Kuhl J.P.; Keohan M.L.; Knotkova H.; Winer R.T.; Griswold G.A.

Afferent fiber-selective shift in opiate potency following targeted opioid receptor knockdown
pp. 365-371(7)
Authors: Jones T.L.; Sweitzer S.M.; Wilson S.P.; Yeomans D.C.

Induction of long-term potentiation of C fibre-evoked spinal field potentials requires recruitment of group I, but not group II/III metabotropic glutamate receptors
pp. 373-379(7)
Authors: Azkue J.J.; Liu X.-G.; Zimmermann M.; Sandkuhler J.

Pharmacogenetic analysis of sex differences in opioid antinociception in rats
pp. 381-391(11)
Authors: Terner J.M.; Lomas L.M.; Smith E.S.; Barrett A.C.; Picker M.J.

Prospective examination of pain-related and psychological predictors of CRPS-like phenomena following total knee arthroplasty: a preliminary study
pp. 393-400(8)
Authors: Harden R.N.; Bruehl S.; Stanos S.; Brander V.; Chung O.Y.; Saltz S.; Adams A.; Stulberg S.D.

The placebo needle, is it a valid and convincing placebo for use in acupuncture trials? A randomised, single-blind, cross-over pilot trial
pp. 401-409(9)
Authors: White P.; Lewith G.; Hopwood V.; Prescott P.

Peripheral group II metabotropic glutamate receptors mediate endogenous anti-allodynia in inflammation
pp. 411-417(7)
Authors: Yang D.; Gereau R.W.

Pain tolerance as a predictor of outcome following multidisciplinary treatment for chronic pain: differential effects as a function of sex
pp. 419-426(8)
Authors: Edwards R.R.; Doleys D.M.; Lowery D.; Fillingim R.B.

Individual differences in diffuse noxious inhibitory controls (DNIC): association with clinical variables
pp. 427-437(11)
Authors: Edwards R.R.; Ness T.J.; Weigent D.A.; Fillingim R.B.

Agreement between percentage pain reductions calculated from numeric rating scores of pain intensity and those reported by patients with acute or cancer pain
pp. 439-442(4)
Authors: Cepeda M.S.; Africano J.M.; Polo R.; Alcala R.; Carr D.B.

The effects of protein phosphatase inhibitors on nociceptive behavioral responses of rats following intradermal injection of capsaicin
pp. 443-451(9)
Authors: Zhang X.; Wu J.; Fang L.; Willis W.D.

Pain coping strategies play a role in the persistence of pain in post-herpetic neuralgia
pp. 453-460(8)
Authors: Haythornthwaite J.A.; Clark M.R.; Pappagallo M.; Raja S.N.

NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release
pp. 461-470(10)
Authors: Juhasz G.; Zsombok T.; Modos E.A.; Olajos S.; Jakab B.; Nemeth J.; Szolcsanyi J.; Vitrai J.; Bagdy G.

Spatial summation of pressure pain: effect of body region
pp. 471-480(10)
Authors: Defrin R.; Ronat A.; Ravid A.; Peretz C.

The development of psychological changes following whiplash injury
pp. 481-489(9)
Authors: Sterling M.; Kenardy J.; Jull G.; Vicenzino B.

Transgenic mice possessing increased numbers of nociceptors do not exhibit increased behavioral sensitivity in models of inflammatory and neuropathic pain
pp. 491-500(10)
Authors: Zwick M.; Molliver D.C.; Lindsay J.; Fairbanks C.A.; Sengoku T.; Albers K.M.; Davis B.M.

Up-regulation of metabotropic glutamate receptor subtypes 3 and 5 in spinal cord in a clinical model of persistent inflammation and hyperalgesia
pp. 501-512(12)
Authors: Dolan S.; Kelly J.G.; Monteiro A.M.; Nolan A.M.

Clinical update
pp. 513-513(1)

Author Index
pp. 515-518(4)

Subject Index
pp. 519-525(7)

Contents
pp. 527-529(3)